Dyne Therapeutics Inc. (DYN)
Market Closed
20 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
23. 45
-0.29
-1.2216%
$
3.93B Market Cap
- P/E Ratio
- Div Yield
2.53M Volume
-3.29 Eps
$ 23.74
Previous Close 
Want to track DYN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Dyne Therapeutics Inc. (DYN) Statistics
Valuation metrics
Market Cap 3.93B
Enterprise value 3.19B
Trailing P/E (ttm) -7.37
Forward P/E -
PEG ratio -0.77
Price/Sales (ttm) -
Price/Book (mrq) 4.53
Enterprise Value/Revenue -
Enterprise Value/EBITDA -7.38
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.36M
Average volume (90 days) 1.67M
Price summary
52-Week low 8.88
52-Week high 25
Beta -
50-Day moving average 19.93
200-Day moving average 17.87
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.42%
Return on equity -0.58%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.74
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.89
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 19.92%
Book value per share (mrq) 5.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
